Skip to main content

Table 3 Radiation and surgical intervention according to primary tumor site

From: Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA

Site Both (%) Radiation only (%) Surgery only (%) Neither rad. nor surgery (%) Total (%)
Bone (SBP)
 Axial skeleton (c41) 177 (21.3%) 481 (57.88%) 58 (6.98%) 115 (13.84%) 831 (49.14%)
 Appendicular skeleton (c40) 30 (20.55%) 78 (53.42%) 15 (10.27%) 23 (15.75%) 146 (8.63%)
Extramedullary plasmacytoma(EMP)
 Upper airway tract [Sino-nasal mouth and pharynx (c00-14, c33-39)] 86 (40.76%) 77 (36.49%) 30 (14.22%) 18 (8.53%) 211 (12.48%)
 Lower airway tract (c32-39) 5 (9.26%) 19 (35.19%) 9 (16.67%) 21 (38.89%) 54 (3.19%)
 Gastrointestinal Tract (c15- 26) 2 (4.08%) 11 (22.45%) 24 (48.98%) 12 (24.49%) 49 (2.9%)
 Soft tissue and connective tissue (c49) 10 (12.99%) 33 (43.86%) 10 (12.99%) 24 (31.17%) 77 (4.55%)
 Central nervous system (c69-72) 17 (34.69%) 15 (30.61%) 16 (32.65%) 1 (2.04%) 49 (3.19%)
 Lymph nodes (c27) 10 (40%) 5 (20%) 5 (20%) 5 (20%) 25 (1.48%)
 Skin (c44) 4 (20%) 6 (30%) 8 (40%) 2 (10%) 20 (1.18%)
 All other sites (c48,50,53,56,67,68,73,74) 7 (12.73%) 14 (25.45%) 20 (36.36%) 14 (25.45%) 55 (3.25%)
Plasmacytoma Unspecified (P-unspecified) 11 (6.67%) 86(49.41%) 2 (1.21%) 75 (43.11%) 174 (10.28%)
Total 359 (21.23%) 825 (48.79%) 197 (11.65%) 310 (18.33%) 1691 (100%)